Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 29.3 | 31.8 | 40.1 | 39.8 | 32.2 | 27.2 | 25.4 | 13.8 |
Revenue growth | -7.8% | -20.7% | 0.7% | 23.8% | 18.3% | 6.9% | 84.2% | 3.2% |
Cost of goods sold | 12.5 | 13.7 | 18.6 | 16.9 | 10.3 | 9.5 | 9.5 | 7.5 |
Gross profit | 16.8 | 18.1 | 21.5 | 22.9 | 21.8 | 17.7 | 15.9 | 6.3 |
Gross margin | 57.2% | 57.0% | 53.6% | 57.6% | 67.8% | 65.2% | 62.6% | 45.5% |
General and administrative | 2.5 | 1.5 | 1.7 | 1.4 | 1.9 | 1.4 | 1.3 | 1.0 |
EBIT | 14.3 | 16.6 | 19.8 | 21.5 | 19.9 | 16.3 | 14.6 | 5.3 |
EBIT margin | 48.8% | 52.3% | 49.5% | 54.0% | 62.0% | 60.0% | 57.5% | 38.3% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|